Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

China flag China · Delayed Price · Currency is CNY
19.91
-0.16 (-0.80%)
Apr 30, 2026, 9:55 AM CST
-20.30%
Market Cap 3.36B
Revenue (ttm) 1.30B
Net Income (ttm) 11.06M
Shares Out 167.44M
EPS (ttm) 0.07
PE Ratio 303.72
Forward PE 16.25
Dividend 0.30 (1.50%)
Ex-Dividend Date Jun 11, 2025
Volume 735,436
Average Volume 3,891,241
Open 19.97
Previous Close 20.07
Day's Range 19.85 - 20.28
52-Week Range 18.81 - 40.19
Beta 0.74
RSI 40.16
Earnings Date Apr 25, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 600
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688687
Full Company Profile

Financial Performance

In 2025, SHA:688687's revenue was 1.32 billion, an increase of 7.35% compared to the previous year's 1.23 billion. Earnings were 30.60 million, a decrease of -78.51%.

Financial Statements

News

There is no news available yet.